Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Eur J Surg Oncol. 2020 Mar 5;46(9):1663–1667. doi: 10.1016/j.ejso.2020.03.003

Table 1.

Patient and tumor characteristics by treatment in stage I anal squamous cell carcinoma (2004-2015)

N (%)
All (n=883) CRT (n=683) LE (n=200) P value*
Age, mean (SD) 60 (12) 60 (11) 60 (13) 0.74
Sex <0.0001
Female 570 (65%) 68% 52%
Male 310 (35%) 32% 48%
Race 0.01
Black 68 (8%) 6% 12%
White 790 (90%) 91% 85%
Other 22 (2%) 2% 3%
Marital Status 0.02
Married 390 (44%) 46% 37%
Unmarried/unknown 490 (56%) 54% 63%
Insurance 0.51
Insured 597 (68%) 69% 65%
Medicaid 85 (10%) 9% 12%
Uninsured 21 (2%) 2% 3%
Unknown 177 (20%) 20% 20%
Metropolitan residence 0.65
Yes 778 (88%) 89% 88%
No 102 (12%) 11% 12%
Tumor Grade <0.0001
Well differentiated 150 (17%) 12% 34%
Moderately differentiated 301 (34%) 36% 28%
Poorly differentiated/undifferentiated 198 (23%) 26% 10%
Unknown 231 (26%) 25% 28%
Tumor Size <0.0001
≤ 1 cm 313 (35%) 29% 59%
>1 to 2 cm 489 (56%) 61% 37%
Unknown 79 (9%) 10% 4%

Abbreviations: CRT=chemoradiation; LE=local excision; SD=standard deviation

*

Chi2 test excluded unknown values